Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer

Published:2019-03 Issue:3 Volume:14 Page:547-552
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lichtenstein Morgan R.L.,Nipp Ryan D.,Muzikansky Alona,Goodwin Kelly,Anderson Danyon,Newcomb Richard A.,Gainor Justin F.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review, 1975-2010. https://seer.cancer.gov/csr/1975_2010/. Accessed January 5, 2018.

2. Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC?;Sacher;J Thorac Oncol,2013

3. The treatment of advanced lung cancer in the elderly: the role of a comprehensive geriatric assessment and doublet chemotherapy;Presley;Cancer J,2015

4. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer;Chrischilles;J Clin Oncol,2010

5. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States;Nadpara;J Geriatr Oncol,2015

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination Trials;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis;Science;2024-09-05

4. Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes;Cancers;2024-07-07

5. Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer;Frontiers in Immunology;2024-06-21